cardiovascular benefits of glp 1 agonists agonist risks GLP-1 receptor agonist-based therapies and risk: a review GLP-1 Agonists in Cardiovascular Diseases:

The effects on delayed gastric emptying, satiety, and decreased caloric intake can promote weight loss

Although these drugs demonstrated effectiveness in improving blood sugar control and promoting weight loss, lawsuits now allege that GLP-1 receptor agonists may also be associated with severe gastrointestinal injuries, optic nerve complications, and other serious adverse health effects

Assessment of gastrointestinal symptoms focuses on nausea, vomiting, early satiety, bloating, and abdominal pain, which correlate with increased gastric retention risk [32]

Editors Note: This article was first published on Jan

Hruby A, Hu FB